QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:AALBF

Aalberts (AALBF) Stock Price, News & Analysis

$46.60
0.00 (0.00%)
(As of 04/18/2024 ET)
Today's Range
$46.60
$46.60
50-Day Range
$37.94
$49.57
52-Week Range
$29.80
$50.07
Volume
69 shs
Average Volume
772 shs
Market Capitalization
N/A
P/E Ratio
36.78
Dividend Yield
0.75%
Price Target
N/A
AALBF stock logo

About Aalberts Stock (OTCMKTS:AALBF)

Aalberts N.V. engineers mission-critical technologies. It operates in two segments: Building Technology and Industrial Technology. The Building Technology segment develops, manufactures, and monitors hydronic flow control systems for heating and cooling to enhance the energy efficiency; and develops, designs, and manufactures integrated piping systems to distribute and regulate water or gas flows in heating, cooling, water, gas, and sprinkler systems in eco-friendly buildings and industrial niches. The Industrial Technology segment co-develops, engineers, and manufactures advanced mechatronics and technologies to regulate, measure, and control fluids under severe and critical conditions for active OEMs in semicon efficiency, sustainable transportation, and industrial niches; and offers a range of surface technologies utilizing a network of service locations local knowledge to customers active in sustainable transportation and industrial niches. It operates in Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific, the Middle East, and Africa. The company was formerly known as Aalberts Industries N.V. and changed its name to Aalberts N.V. in April 2019. Aalberts N.V. was founded in 1975 and is headquartered in Utrecht, the Netherlands.

AALBF Stock Price History

AALBF Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Aalberts NV AALBF
Aalberts NV AALB
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Aalberts N.v. Share Price (AALB.AM)
Aalberts N.V. reports results
Why Aalberts N.V. (AMS:AALB) Could Be Worth Watching
See More Headlines
Receive AALBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aalberts and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Specialty Industrial Machinery
Sub-Industry
N/A
Current Symbol
OTCMKTS:AALBF
CIK
N/A
Fax
N/A
Employees
14,055
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Arno R. Monincx (Age 57)
    CFO & Member of Management Board
    Comp: $1.01M
  • Mr. Stéphane Simonetta (Age 52)
    CEO & Member of the Management Board
  • Mr. Marcel A. J. M. Abbenhuis (Age 65)
    Executive Director
  • Mr. Maarten Van De Veen
    Executive Director
  • Mr. André in Het Veld
    Executive Director
  • Mr. Thomas Breser
    Member of the Management Team - Advanced Mechatronics Group

AALBF Stock Analysis - Frequently Asked Questions

How have AALBF shares performed in 2024?

Aalberts' stock was trading at $43.35 at the beginning of the year. Since then, AALBF shares have increased by 7.5% and is now trading at $46.5990.
View the best growth stocks for 2024 here
.

Are investors shorting Aalberts?

Aalberts saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 297,300 shares, an increase of 14.0% from the February 29th total of 260,700 shares. Based on an average daily trading volume, of 700 shares, the short-interest ratio is presently 424.7 days.
View Aalberts' Short Interest
.

Is Aalberts a good dividend stock?

Aalberts (OTCMKTS:AALBF) pays an annual dividend of $0.35 per share and currently has a dividend yield of 1.62%. The dividend payout ratio is 27.50%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Aalberts?

Shares of AALBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AALBF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners